Evaluation of IL-1RA, IL-1β IFN-γ and CXCL-10 as mediators of damage and hepatic repair in chronic hepatitis and fibrosis progresion

• A. Hernández-Barragán,
• J. Limón-Castillo,
• M. Martínez-Castillo,
• D. Rosique-Oramas,
• J.L. Pérez-Hernández,
• F. Higuera-De la Tijera,
• P. Cordero-Pérez,
• L. Muñoz-Espinosa,
• D. Kershenobich,
• G. Gutiérrez-Reyes

Affiliations

A. Hernández-Barragán

Liver, Pancreas and Motility laboratory, Unit of Experimental Medicine, School of Medicine, National Autonomous University of Mexico (UNAM), General Hospital of Mexico, Mexico City, Mexico

J. Limón-Castillo

Liver, Pancreas and Motility laboratory, Unit of Experimental Medicine, School of Medicine, National Autonomous University of Mexico (UNAM), General Hospital of Mexico, Mexico City, Mexico

M. Martínez-Castillo

Liver, Pancreas and Motility laboratory, Unit of Experimental Medicine, School of Medicine, National Autonomous University of Mexico (UNAM), General Hospital of Mexico, Mexico City, Mexico

D. Rosique-Oramas

Liver, Pancreas and Motility laboratory, Unit of Experimental Medicine, School of Medicine, National Autonomous University of Mexico (UNAM), General Hospital of Mexico, Mexico City, Mexico

J.L. Pérez-Hernández

General Hospital of Mexico “Dr. Eduardo Liceaga”, Department of Gastroenterology, Mexico City

F. Higuera-De la Tijera

General Hospital of Mexico “Dr. Eduardo Liceaga”, Department of Gastroenterology, Mexico City

P. Cordero-Pérez

University Hospital “Dr. José Eleuterio González”, School of Medicine, UANL, Nuevo Leon, México

L. Muñoz-Espinosa

University Hospital “Dr. José Eleuterio González”, School of Medicine, UANL, Nuevo Leon, México

D. Kershenobich

National Institute of Medical Sciences and Nutrition “Salvador Zubirán”, Mexico City

G. Gutiérrez-Reyes

Liver, Pancreas and Motility laboratory, Unit of Experimental Medicine, School of Medicine, National Autonomous University of Mexico (UNAM), General Hospital of Mexico, Mexico City, Mexico